Tag: Drug development

April 7, 2026

Zodasiran Lowers Triglycerides and LDL Cholesterol in Phase 1 Trial

April 7, 2026

Trump Budget Proposes Boost for U.S. Drug Manufacturing

April 5, 2026

Trump Tariffs Drive Drugmakers Toward Confidential Pricing Agreements

March 31, 2026

NR4A1 Drives Immune Evasion and Resistance to Therapy in Pancreatic Cancer

March 26, 2026

FDA Approvals & Biotech Updates: Denali, Sarepta, Corcept & Allogene

March 26, 2026

Adam’s Biotech Scorecard: Why I Suffer as a Tottenham Hotspur Fan | STAT+ Exclusive

March 25, 2026

FDA Approves Denali’s Hunter Syndrome Drug Despite Rare Disease Scrutiny

March 25, 2026

Sarepta Stock Jumps on Positive Early Trial Data for Muscular Dystrophy Drugs

March 25, 2026

Merck Buys Terns Pharma for $6.7B: Leukemia Drug Deal

March 25, 2026

Merck to Acquire Terns Pharmaceuticals for $6.7 Billion | STAT+ Exclusive